COMMUNIQUÉS West-GlobeNewswire

Todos Medical Presents Encouraging Scientific Abstract at the San Antonio Breast Cancer Symposium (SABCS)
06/12/2018
TM-B1 Cancer Screen Test Shown to Contribute to Early Detection of Breast Cancer REHOVOT, Israel, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company [...]
With Strategic Acquisition, Plus Products Expands Capacity & Offering -- CFN Media
06/12/2018
SEATTLE, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
The Cancer Research Collaboration Partners with Diabetes Prevention Program Provider Blue Mesa Health with California Residents in Mind
06/12/2018
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The Cancer Research Collaboration (CRC), a non-profit organization dedicated to expanding the availability of cutting-edge cancer research, in partnership with RadNet, Inc. ( [...]
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
06/12/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
06/12/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Recording of the Third Quarter 2018 Investor Conference Webinar
06/12/2018
On December 6 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the Advisor to the Board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of third quarter 2018 and informed [...]
Honolulu Ophthalmologist Implants First Visian® Toric ICL in Hawaii
06/12/2018
Dr. Alan Faulkner of Aloha Laser Vision uses the FDA-approved Visian Toric ICL (TICL) to treat myopic astigmatism in patients who are not good candidates for laser vision correction surgery HONOLULU, Dec. 06, 2018 ( [...]
Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Day
06/12/2018
EB-101 pivotal trial for Recessive Dystrophic Epidermolysis Bullosa planned for mid-2019 enrollment Expanding Phase I/II study of ABO-102 for Sanfilippo syndrome type A (MPS IIIA) Novel AIM TM AAV vector with CFTR [...]
IBA SA: data concerning transparency
06/12/2018
IBA – DATA CONCERNING TRANSPARENCY Heading II of the law of May 2, 2007 and the Royal Decree of February 14, 2008 Louvain-la-Neuve, Belgium, December 3, 2018 - IBA (Ion Beam Applications SA), the world’s leading [...]
IBA SA: information en matière de transparence
06/12/2018
IBA - INFORMATIONS EN MATIERE DE TRANSPARENCE Titre II de la loi du 2 mai 2007 et Arrêté Royal du 14 février 2008 Louvain-la-Neuve, Belgique, 3 décembre 2018 – IBA (Ion Beam Applications SA), le premier fournisseur [...]
VALNEVA and HOOKIPA Sign a Collaboration and Manufacturing Agreement
06/12/2018
Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement Saint-Herblain, France, and Vienna, Austria, December 06, 2018 - Valneva Sweden AB, the Swedish subsidiary of Valneva SE ("Valneva"), and HOOKIPA [...]
VALNEVA et HOOKIPA signent un accord de collaboration et de fabrication
06/12/2018
Valneva et Hookipa signent un accord de collaboration et de fabrication Saint-Herblain, France et Vienne, Autriche, 6 décembre 2018 - Valneva Sweden AB, la filiale suédoise de Valneva SE ("Valneva"), et Hookipa Pharma [...]
Novartis investigational BYL719 (alpelisib) plus fulvestrant consistently improved PFS in patients with PIK3CA mutated HR+/HER2- advanced breast cancer in new SOLAR-1 analyses
06/12/2018
BYL719 plus fulvestrant meaningfully prolonged PFS vs fulvestrant alone in patients with PIK3CA mutated HR+/HER2- advanced breast cancer after progression on an aromatase inhibitor or after receiving up to one [...]
TOMI Environmental Solutions, Inc. Launches “FRST” a Forensic Restoration Service Team, Partnering With The Global BioRisk Advisory Council(GBAC)
06/12/2018
BEVERLY HILLS, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company that specializes in disinfection and decontamination essentials using its premier [...]
Aleafia Announces Results of Special Shareholders Meeting
06/12/2018
Company to Immediately Pursue NASDAQ Application Final Stages TORONTO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “ Company “), is announcing the [...]
Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI
06/12/2018
SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided a business update announcing the U.S. launch of FDA-approved SYMJEPI ™ (epinephrine) 0.3mg Injection is [...]
Phoenix Life Sciences International Announces the Release of the Company’s Investor Relations Deck and Accompanying Video Presentation
06/12/2018
DENVER, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has released an online [...]
Medidata Selects Client Outlook’s eUnity™ Smartviewer to Enable Zero-Footprint Image Viewing for Life Sciences Research
06/12/2018
WATERLOO, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Client Outlook , a leading provider of FDA Class II clinical and diagnostic image viewing solutions, announced today its partnership with Medidata to support the use [...]
Matinas BioPharma Assembles World Class Scientific Advisory Board to Guide Clinical Development Strategy of Potential Best-in-Class Prescription-Only Omega-3, MAT9001
06/12/2018
Christie M. Ballantyne, M.D., John J.P. Kastelein, M.D., Ph.D., FESC, and Kevin C. Maki, Ph.D. represent three of the world’s leading lipid specialists and cardiovascular health experts BEDMINSTER, N.J., Dec. 06, 2018 ( [...]

Pages